Article info

Download PDFPDF
Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration

Authors

  1. Correspondence to S James Talks, Department of Ophthalmology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; James.Talks{at}nuth.nhs.uk
View Full Text

Citation

Pushpoth S, Sykakis E, Merchant K, et al
Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration

Publication history

  • Accepted August 18, 2012
  • First published September 21, 2012.
Online issue publication 
November 20, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.